What is the translation of " LUMINITY " in English?

• luminity

Examples of using Luminity in Croatian and their translations into English

Ako dobijete više Luminityja nego što ste trebali.
If you are given more Luminity than you should.

Luminity je plin i otapalo za disperziju za injekciju ili infuziju.
Luminity is a gas and solvent for dispersion for injection or infusion.

Potreban je oprez kada se razmatra primjena Luminityja tim bolesnicima.
Caution must be exercised when considering the administration of Luminity to these patients.

Luminity nije posebno ispitivan u bolesnika s oštećenjem jetre.
Luminity has not been specifically studied in patients with hepatic impairment.

Vialmix nije uključen u pakiranje Luminityja, ali će ga zdravstveni radnici dobiti kada naruče pakiranje.
The Vialmix is not included in the Luminity pack but will be provided to healthcare professionals upon ordering the pack.

Luminity 150 mikrolitara/ml plin i otapalo za disperziju za injekciju/infuziju perflutren.
Luminity 150 microlitres/ml gas and solvent for dispersion for injection/infusion perflutren.

Prije aktivacije(miješanja) sadržaja bočice Luminity izgleda kao bezbojna, jednolično bistra do prozirna tekućina.
Before activation(shaking) the contents of the vial, Luminity appears as a colourless, uniformly clear to translucent liquid.

Luminity se takvim bolesnicima smije primjenjivati samo nakon pažljive procjene rizika/koristi.
Luminity should only be administered to such patients after careful risk/benefit assessment.

Recite svom liječniku ako ste trudni ili dojite i obratite se svom liječniku ili ljekarniku za savjet prije nego što dobijete Luminity.
Tell your doctor if you are pregnant or breast-feeding and ask your doctor or pharmacist for advice before you are given Luminity.

Komponenta perflutrena u Luminityju brzo se uklonila iz sistemskog krvotoka putem pluća.
The perflutren component of Luminity was rapidly cleared from the systemic circulation via the lungs.

Ozbiljne neposredne reakcije preosjetljivosti(npr. anafilaksa, anafilaktički šok i anafilaktoidne reakcije, hipotenzija i angioedem) zabilježeni su nakon primjene Luminityja.
Serious immediate hypersensitivity reactions(eg: anaphylaxis, anaphylactic shock and anaphylactoid reactions, hypotension and angioedema) have been reported following the administration of Luminity.

Luminity se ne smije primjenjivati metodama koje nisu navedene u dijelu 4.2 npr. injekcijom u arteriju.
Luminity should not be administered by methods not specified in section 4.2 e.g. intra-arterial injection.

Poremećeno disanje, promjene srčane frekvencije i smanjena aktivnost bili su uočeni ubrzo nakon intravenske injekcije Luminityja u dozama od  0, 3 ml/kg u ispitivanjima toksičnosti jednokratnih i opetovanih doza provedenima na štakorima i majmunima.
Abnormal respiration, heart rate changes and decreased activity were observed soon after intravenous injection of Luminity at doses 0.3 ml/kg in single and repeat-dose toxicity studies in rats and monkeys.

Luminity se ne smije koristiti u djece i adolescenata(mlađih od 18 godina) jer nije ispitan u tim skupinama.
Luminity should not be used in children and adolescents(under 18 years of age) as it has not been studied in these groups.

Mjerenja Doppler ultrazvukom s Luminityjem provedena su zajedno s farmakokinetičkom evaluacijom perflutrena.
Doppler ultrasound measurements were performed with Luminity in conjunction with the pharmacokinetic evaluation of perflutren.

Luminity je ultrazvučno kontrastno sredstvo koje sadrži mikrosfere(sitne mjehuriće) plina perflutrena kao djelatnu tvar.
Luminity is an ultrasound contrast agent that contains microspheres(tiny bubbles) of perflutren gas as the active substance.

Sigurnost primjene Luminityja u bolesnika s desno-lijevim, dvosmjernim ili prolaznim desno-lijevim srčanim spojevima nije ispitivana.
The safety of Luminity in patients with right-to-left, bi-directional or transient right-to-left cardiac shunts has not been studied.

Luminity se može razrijediti s 0,9% tne(9 mg/ml) otopinom natrijevog klorida za injekciju ili 5%- tne(50 mg/ml) otopinom glukoze za injekciju.
Luminity may be diluted with sodium chloride 9 mg/ml(0.9%) solution for injection or glucose 50 mg/ml(5%) solution for injection.

U kliničkim ispitivanjima s Luminityjem korištene su osnovne i nelinearne tehnike snimanja(„second harmonic”,„multipulse phase” i/ili„amplitude modulation”) koje koriste i kontinuirane i pulsirajuće signale.
Fundamental and non-linear imaging techniques(second harmonic, multipulse phase and/or amplitude modulation) using both continuous and triggered acquisition were utilised in clinical studies with Luminity.

Luminity će Vam prije ili tijekom pregleda ultrazvukom dati zdravstveni radnik kao što je liječnik koji ima iskustva s takvom vrstom pregleda.
Luminity is given to you before or during your ultrasound examination by healthcare professionals such as doctors who are experienced in this type of examination.

Štakori koji su primali Luminity tijekom 1 mjeseca imali su s dozom povezanu, reverzibilnu perivaskularnu i peribronhiolarnu infiltraciju eozinofila, alveolarno nakupljanje makrofaga te povećanu veličinu i broj vrčastih stanica u plućima.
Rats treated with Luminity for 1 month exhibited dose-related, reversible perivascular and peribronchiolar eosinophil infiltration, alveolar macrophage accumulation and increased goblet cell size and number in the lungs.

Luminity se ne smije koristiti uz osnovnu tehniku snimanja za ehokardiografiju pod opterećenjem budući da njegova djelotvornost i sigurnost primjene nisu utvrđene.
Luminity should not be used with fundamental imaging technique for stress echocardiography since efficacy and safety have not been established.

Nuspojave zabilježene nakon primjene Luminityja u pivotalnim i suportivnim ispitivanjima(ukupno 2526 bolesnika) javljale su se u roku od nekoliko minuta od primjene i obično se povukle uz terapijsku intervenciju u roku od 15 minuta.
The reported adverse reactions following the use of Luminity in pivotal and supportive trials(total of 2,526 patients) occur within minutes after administration and usually resolve without therapeutic intervention within 15 minutes.

Luminity se prije uporabe mora aktivirati tako da se protrese s pomoću mehaničkog uređaja koji se naziva Vialmix i koji se isporučuje liječnicima koji trebaju pripremiti lijek.
Before use, Luminity must be activated by shaking it using a mechanical device called Vialmix, which is supplied to doctors who need to prepare the medicine.

Prirodni fosfolipidi u Luminityju(vidjeti dio 6.1) raspodijeljeni su u endogenim nakupinama lipida u tijelu(primjerice, jetri), dok se za sintetičku komponentu(MPEG5000) u nekliničkim ispitivanjima pokazalo da se izlučuje u mokraću.
The naturally occurring phospholipids in Luminity(see section 6.1) are distributed in the endogenous lipid pools in the body(for example, liver) whereas the synthetic component(MPEG5000) has been shown to be excreted in the urine in preclinical studies.

Luminity se koristi u odraslih osoba da bi se dobila jasnija slika srčanih komora, osobito lijeve klijetke, tijekom ehokardiografije dijagnostičke pretrage tijekom koje se korištenjem ultrazvuka dobiva snimka srca.
Luminity is used in adults to obtain a clearer scan of the chambers of the heart, especially of the left ventricle, during echocardiography a diagnostic test where an image of the heart is obtained using ultrasound.

Izniman oprez potreban je kada se razmatra primjena Luminityja u bolesnika s nestabilnim kardiopulmonalnim statusom, primjerice: s nestabilnom anginom, akutnim infarktom miokarda, teškim ventrikularnim aritmijama, teškim srčanim zatajenjem(NYHA IV) ili respiratornim zatajenjem.
Extreme caution should be used when considering the administration of Luminity to patients with unstable cardiopulmonary status, for example: unstable angina, acute myocardial infarction, severe ventricular arrhythmias, severe heart failure(NYHA IV) or respiratory failure.

Budući da Luminity nema farmakološki učinak te na temelju njegovog farmakokinetičkog i farmakodinamičkog profila, očekuje se da ne utječe ili da zanemarivo utječe na sposobnost upravljanja vozilima ili rada sa strojevima.
As Luminity has no pharmacologic effect, and on the basis of its pharmacokinetic and pharmacodynamic profiles, no or negligible influence is expected with the use of this product on the ability to drive or use machines.

Luminity se koristi u bolesnika sa potvrđenom bolešću koronarnih arterija(začepljenjem krvnih žila koje opskrbljuju srčani mišić) ili sumnjom na takvu bolest, kada slika dobivena nekontrastnom ehokardiografijom nije optimalna.
Luminity is used in patients with suspected or confirmed coronary artery disease(obstruction of the blood vessels supplying the heart muscle), when the image obtained with non- contrast echocardiography is not optimal.

Luminity se zatim daje u venu bilo kao‘bolus' injekcija(koja se daje odjednom) ili kao infuzija(otopina za kapanje) nakon razrjeđivanja s 9 mg/ml(0,9%) otopinom natrijevog klorida ili 50 mg/ml(5%) otopinom glukoze za injekciju.
Luminity is then given into a vein either as a‘bolus' injection(given all at once) or as an infusion(drip solution) after being diluted with sodium chloride 9 mg/ml(0.9%) or glucose 50 mg/ml(5%) solution for injection.